Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.28.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EG.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.39.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
XDQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.47.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HV.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.42.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.48.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.16.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JD.1.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
JG.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.58SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used